News
March 8, 2023 News
Report launch: The Swedish Drug Discovery and Development Pipeline 2023
SwedenBIO launches the long-awaited 2023 edition of the large, recurring mapping of the Swedish pharmaceutical pipeline.
February 8, 2023 News
Oblique Therapeutics offentliggör utfall i genomförd företrädesemission
January 30, 2023 Event
Oblique Therapeutics is pleased to be participating in the Biotechgate Digital Partnering event
Virtual Business development and Licensing event - Feb 6 -10, 2023
January 4, 2023 News
Announcement of Oblique Therapeutics ‘s Rights Issue 2023
January 3, 2023 Event
Oblique Therapeutics is thrilled to be attending in person at the 41st Annual J.P. Morgan Healthcare Conference
January 9—12, 2023 | San Francisco, CA
December 22, 2022 Event
Oblique Therapeutics is pleased to take part digitally to the next BIO Partnering JPM Week: January 9-12, 2023
November 30, 2022 Event
Oblique Therapeutics is thrilled to take part to the next PLCF Event in France
6th December 2022- Paris
November 23, 2022 Event
Oblique Therapeutics is excited to be participating in the Biotechgate Digital Partnering event
Nov 28 - Dec 2, 2022 a great opportunity to establish new global connections!
November 11, 2022 Event
Oblique Therapeutics takes part to the 11th Drug Discovery Strategic Summit
November 10th-11th 2022 - Amsterdam - Netherland
November 9, 2022 News
Oblique Therapeutics is pleased to announce the nomination of Christer Nordstedt M.D. Ph.D. as Chief Executive Officer
the new CEO will assume the position on 1st December 2022.